Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers
Biomolecules · 24.11.2023 · 13 (12) · 1701
DOI: 10.3390/biom13121701 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 24.11.2023. Verfasst von Sebastiano Giallongo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Neoplasms, Mesenchymal Stem Cells. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mesenchymal stromal cells (MSCs) are a subset of heterogeneous, non-hematopoietic fibroblast-like cells which play important roles in tissue repair, inflammation, and immune modulation. MSCs residing in the bone marrow microenvironment (BMME) functionally interact with hematopoietic stem progenitor cells regulating hematopoiesis. However, MSCs have also emerged in recent years as key regulators of the tumor microenvironment. Indeed, they are now considered active players in the pathophysiology of hematologic malignancies rather than passive bystanders in the hematopoietic microenvironment. Once a malignant event occurs, the BMME acquires cellular, molecular, and epigenetic abnormalities affecting tumor growth and progression. In this context, MSC behavior is affected by signals coming from cancer cells. Furthermore, it has been shown that stromal cells themselves play a major role in several hematological malignancies’ pathogenesis. This bidirectional crosstalk creates a functional tumor niche unit wherein tumor cells acquire a selective advantage over their normal counterparts and are protected from drug treatment. It is therefore of critical importance to unveil the underlying mechanisms which activate a protumor phenotype of MSCs for defining the unmasked vulnerabilities of hematological cancer cells which could be pharmacologically exploited to disrupt tumor/MSC coupling. The present review focuses on the current knowledge about MSC dysfunction mechanisms in the BMME of hematological cancers, sustaining tumor growth, immune escape, and cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, 95123 Catania, Italy.
- Division of Hematology, AOU Policlinico, 95123 Catania, Italy.
- Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
- Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy.
ORCID-Profile: Andrea Duminuco, Tatiana Zuppelli, Alessandra Romano, Daniele Tibullo, Giuseppe A Palumbo
Zitieren
APA
Giallongo, S., Duminuco, A., Dulcamare, I., Zuppelli, T., La Spina, E., Scandura, G., Santisi, A., Romano, A., Di Raimondo, F., Tibullo, D., Palumbo, G. A., & Giallongo, C. (2023). Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers. Biomolecules, 13(12), 1701. https://doi.org/10.3390/biom13121701
Vancouver
Giallongo S, Duminuco A, Dulcamare I, Zuppelli T, La Spina E, Scandura G, et al. Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers. Biomolecules. 2023;13(12):1701. doi:10.3390/biom13121701
BibTeX
@article{Giallongo2023,
author = {Giallongo, Sebastiano and Duminuco, Andrea and Dulcamare, Ilaria and Zuppelli, Tatiana and La Spina, Enrico and Scandura, Grazia and Santisi, Annalisa and Romano, Alessandra and Di Raimondo, Francesco and Tibullo, Daniele and Palumbo, Giuseppe A and Giallongo, Cesarina},
title = {Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {12},
pages = {1701},
doi = {10.3390/biom13121701}
}
EUVIMED